Cargando...
Incremental cost-effectiveness of the second Xpert MTB/RIF assay to detect Mycobacterium tuberculosis
BACKGROUND: Due to the non-homogeneity of specimens collected from tuberculosis (TB) suspects, repeated Xpert MTB/RIF (Xpert) may have potential clinical benefits. Incremental cost-effectiveness was analyzed for the second Xpert assay to detect Mycobacterium tuberculosis (Mtb) and rifampicin (RIF) r...
Guardado en:
| Publicado en: | J Thorac Dis |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906334/ https://ncbi.nlm.nih.gov/pubmed/29707322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.02.60 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|